Tuesday, September 9, 2008

Re: the techcrunch 50

Imagine being able to do this virtually! (although i'd like to be at this one in the sf flesh)

But reverting to last night's brainstorm...

this was the core of my idea around rippledown rules and expert systems evaluating experimental merit for investment in new medicine or medical techniques - especially useful in the need to get better cheaper medicine for 3rd world countries where there is no financial incentive from western companies eg. HIV treatments, vaccines etc.


No comments: